1 active not recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Myeloid Neoplasm: new trials by email Literature Review of Myeloid Neoplasm trials Research Report on Myeloid Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Azacitidine, Pevonedistat, Venetoclax - Acute Myeloid Leukemia, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Phase 1 / Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 40 | 2019-02-27 | 2026-07-16 |
Hypereosinophilic Syndrome (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1) · Leukemia, Myelomonocytic, Chronic (1) · Leukemia, Neutrophilic, Chronic (1) · Myelodysplastic Syndromes (1) · Myeloproliferative Disorders (1) · Polycythemia Vera (1) · Primary Myelofibrosis (1) · Thrombocythemia, Essential (1) · Thrombocytosis (1)
Blood Coagulation Disorders (1) · Blood Platelet Disorders (1) · Bone Marrow Diseases (1) · Bone Marrow Neoplasms (1) · Chronic Disease (1) · Disease Attributes (1) · Eosinophilia (1) · Hematologic Diseases (1) · Hematologic Neoplasms (1) · Hemic and Lymphatic Diseases (1) · Hemorrhagic Disorders (1) · Leukemia (1) · Leukemia, Myeloid (1) · Leukocyte Disorders (1) · Myelodysplastic-Myeloproliferative Diseases (1)
Azacitidine (1) · pevonedistat (1) · venetoclax (1)
M.D. Anderson Cancer Center (1)
United States (1)
Nicholas Short (1)